HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Preventive effect of an immunomodulator, OM-85 BV, on acute exacerbations of chronic bronchitis in elderly patients. Preliminary results at six months in 291 patients].

Abstract
Three hundred fifty six patients aged 65 years or more (mean age 81.8 years) who were suffering from chronic bronchitis were included in a double-blind trial against placebo to assess the preventative effect of OM-85 BV against acute exacerbations of chronic bronchitis. OM-85 BV is an immunostimulant composed of lyophilised factions of 8 bacteria which are most frequently encountered during the course of respiratory tract infections. 291 patients completed the study. In the group treated by OM-85 BV, a significant increase in the number of patients with no episode of acute bronchitis was noted (96 versus 71, p = 0.006). There was a 38.8% reduction in the absolute numbers of episodes of acute bronchitis and a 33% reduction in the number of prescriptions for antibiotics, however there was no difference in the number of pneumonias and bronchopneumonias. These results show the protective effect of OM-85 BV against bronchial superinfections in a large population of elderly patients suffering from chronic bronchitis.
AuthorsB Orcel, B Delclaux, M Baud, J P Derenne
JournalRevue des maladies respiratoires (Rev Mal Respir) Vol. 10 Issue 1 Pg. 23-8 ( 1993) ISSN: 0761-8425 [Print] France
Vernacular TitleEffet préventif d'un immunomodulateur, l'OM-85 BV, sur les exacerbations aiguës de bronchite chronique du sujet âgé. Résultats préliminaires à 6 mois chez 291 patients.
PMID8451491 (Publication Type: Clinical Trial, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Adjuvants, Immunologic
  • Broncho-Vaxom
  • Cell Extracts
  • Immunoglobulins
Topics
  • Acute Disease
  • Adjuvants, Immunologic (administration & dosage, pharmacology, therapeutic use)
  • Aged
  • Bacteria
  • Blood Cell Count
  • Blood Gas Analysis
  • Bronchitis (complications, diagnosis, drug therapy)
  • Cell Extracts
  • Chronic Disease
  • Double-Blind Method
  • Female
  • Humans
  • Immunoglobulins (blood)
  • Incidence
  • Male
  • Middle Aged
  • Paris (epidemiology)
  • Prospective Studies
  • Respiratory Tract Infections (epidemiology, etiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: